KLK3 and Familial prostate cancer: Additionally, PSA testing rates changed differently over time in different countries, and although we tested for an effect of changing PSA testing rates over time using meta-regression, we may not have been able to capture differences in effect estimates for prostate cancer between studies from changing PSA testing rates, as well as differences between countries.